Instrumax (Tianjin) Co., Ltd.

Main products: Other Mass Spectrometer

Gold Member Business License 3 Years in Business
Home/ News/ The event concluded | Ingram Micro Instruments appeared at the 10th Small Nucleic Acid Conference, using domestic CAD technology to empower nucleic acid drug quality control innovation

The event concluded | Ingram Micro Instruments appeared at the 10th Small Nucleic Acid Conference, using domestic CAD technology to empower nucleic acid drug quality control innovation

Aug 10, 2026•Instrumax (Tianjin) Co., Ltd.

Company News


The event ends | Ingram Micro Instruments debuted at the 10th Small Nucleic Acid Conference, featuring domesticCADTechnology empowers nucleic acid drug quality control innovation

01 Ten years of industry events to explore the new future of the nucleic acid industry

Recently, the 10th China (Tianjin) Nucleic Acid Drug Conference concluded successfully. As a benchmark industry event in the field of small nucleic acids for ten years, the conference focuses onsiRNA、ASO、LNPdelivery system,CMCIn the core directions of quality control and industrial transformation, more than a thousand industry experts, scientific researchers and pharmaceutical company R&D personnel have gathered to jointly explore new paths for technological breakthroughs and industrialization of nucleic acid drugs.

【picture1:Panorama of the conference site|The grand scene of the 10th China Nucleic Acid Drug Conference】

Deeply exploring the track of domestic high-end analytical instruments, Ingram Micro Instruments brings self-developedCADetector a1Electrospray detectors participated in the exhibition to face the quality control pain points in the development and production of small nucleic acid drugs, and provide the industry with stable, compliant, and cost-effective full-process localized analysis solutions.

02 Focus on industry pain points and solve quality control bottlenecks

With the rapid rise of the domestic small nucleic acid industry, shortcomings in quality control analysis have gradually become prominent, becoming a key bottleneck restricting the development of the industry. oligonucleotide,LNPLipid components have no UV absorption, traditionalUVThe detector cannot achieve effective quantification; synthetic truncated impurities and trace degradation products are difficult to accurately identify. Conventional equipment has unstable baselines and insufficient sensitivity, and cannot meet the pharmacopoeia requirements.pgLevel trace detection requirements. At the same time, importCADEquipment procurement costs are high, operation and maintenance is expensive, and after-sales services are lagging behind. The industry is in urgent need of mature and reliable domestic alternatives.

03 Hard-core domestic solution, fully covering small nucleic acid quality control scenarios

Appeared this timeCADetector a1The electrospray detector relies on its own patented aerosol electrification detection technology to break through the limitations of traditional detection. It does not require the sample to have UV absorption characteristics and is fully suitable for small nucleic acid raw materials, preparations andLNPFull chain inspection requirements for delivery systems.

Figure 2.png

【picture2:Ingram Micro Instruments Booth|Self-developedCADetector a1Products unveiled at the exhibition]

The equipment can accurately measuresiRNA、ASOPurity and trace impurities, complete separationLNPFour core lipid components with sensitivity up topglevel, with wide linear range and excellent data reproducibility, fully meeting the requirements for R&D testing and declaration compliance. The equipment can seamlessly match the mainstream in the marketHPLC、UPLCThe system has low transformation costs and simple daily operation and maintenance, truly realizing the local replacement of imported equipment.

 Figure 3.png

【picture3:Technology display|Small nucleic acids,LNPSchematic representation of chromatographic effects and principles of lipid detection]

04 In-depth industry-university-research exchanges help industries improve quality and efficiency

During the exhibition, Ingram Micro's technical team conducted in-depth exchanges with industry experts and R&D practitioners. Targeting different scenarios such as rapid project establishment by start-ups, mass production quality control of pharmaceutical companies, and scientific research method development in universities, Ingram Micro's technical team customized one-to-one analysis solutions and shared cases of mature and implementable detection methods to help customers shorten the research and development cycle, reduce experimental costs, and accelerate project application and implementation.

 Figure 4.png

【picture4: On-site communication|Technical team answers questions for customers on one-on-one solutions]

05 Deeply cultivate segmented tracks and continue to empower industrial innovation

Participating in this conference fully demonstrated Ingram Micro’s domestic technical strength and determination to deepen the industry. In the future, Ingram Micro Instruments will continue to iterateCADCore detection technology, improve the exclusive method library of small nucleic acids, liposomes, and peptide biomedicine, adhere to independent research and development, domestic innovation, use reliable instrument power to help domestic small nucleic acid drugs improve the quality and efficiency, and accelerate more innovative results to go to clinical practice and achieve industrialization.

If you need to obtain small nucleic acids,LNPLipid-specific detection method manual and one-to-one technical docking, welcome to leave a message for consultation in the background!

#The 10th China Nucleic Acid Drug Conference#Small nucleic acid drug quality control#LNPDetection#CADElectrospray detector#Domestic analytical instruments#Ingram Micro Instruments


View More from This Booth